American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$255M |
| 2 |
Texas Instruments
TXN
|
+$186M |
| 3 |
American Tower
AMT
|
+$166M |
| 4 |
SLB Ltd
SLB
|
+$160M |
| 5 |
3M
MMM
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$2.53B |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$516M |
| 3 |
PepsiCo
PEP
|
+$341M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$316M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$312M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.32% |
| 2 | Healthcare | 13.4% |
| 3 | Technology | 12.6% |
| 4 | Industrials | 11.13% |
| 5 | Consumer Discretionary | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Agilent Technologies
A
$42.3B
| $230M | 0.24% |
4,343,564
+6,457
| +0.1% | +$326K |
|
127
M&T Bank
MTB
$36.7B
| $228M | 0.24% |
1,473,607
+6,491
| +0.4% | +$1.05M |
|
|
INFO
128
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $227M | 0.24% |
5,405,976
+2,686,353
| +99% | +$106M |
|
129
Parker-Hannifin
PH
$135B
| $224M | 0.23% |
1,394,572
-9,476
| -0.7% | -$1.44M |
|
130
Xcel Energy
XEL
$48.3B
| $223M | 0.23% |
5,014,210
-382,250
| -7% | -$16.2M |
|
131
Keysight
KEYS
$58.5B
| $221M | 0.23% |
6,112,660
+843,676
| +16% | +$31.4M |
|
132
Autodesk
ADSK
$53.4B
| $219M | 0.23% |
2,530,568
+462,803
| +22% | +$38.7M |
|
133
DuPont de Nemours
DD
$19.5B
| $218M | 0.23% |
1,355,257
-591,936
| -30% | -$91.9M |
|
134
Boston Scientific
BSX
$74.4B
| $218M | 0.23% |
8,760,384
-2,203,366
| -20% | -$53.6M |
|
135
Atmos Energy
ATO
$28.5B
| $216M | 0.22% |
2,738,696
+425,986
| +18% | +$32.7M |
|
136
Reinsurance Group of America
RGA
$16.1B
| $216M | 0.22% |
1,698,903
-394,305
| -19% | -$50M |
|
137
Dollar Tree
DLTR
$24.5B
| $215M | 0.22% |
2,735,826
-50,097
| -2% | -$3.85M |
|
138
SiriusXM
SIRI
$9.65B
| $211M | 0.22% |
4,103,073
-870,636
| -18% | -$42.8M |
|
|
K
139
DELISTED
Kellanova
K
| $211M | 0.22% |
3,094,230
-993,741
| -24% | -$68.6M |
|
140
Commerce Bancshares
CBSH
$8.51B
| $211M | 0.22% |
5,814,820
-911,108
| -14% | -$33.6M |
|
141
Aflac
AFL
$61B
| $210M | 0.22% |
5,798,626
+321,504
| +6% | +$11.4M |
|
142
Quest Diagnostics
DGX
$26.3B
| $209M | 0.22% |
2,132,929
-126,847
| -6% | -$12.1M |
|
|
CXO
143
DELISTED
CONCHO RESOURCES INC.
CXO
| $208M | 0.22% |
1,622,118
+28,520
| +2% | +$3.84M |
|
|
ESRX
144
DELISTED
Express Scripts Holding Company
ESRX
| $205M | 0.21% |
3,117,024
+195,305
| +7% | +$13.4M |
|
145
Ameriprise Financial
AMP
$49.9B
| $203M | 0.21% |
1,566,984
+278,600
| +22% | +$34.5M |
|
146
Fidelity National Information Services
FIS
$22.2B
| $203M | 0.21% |
2,552,198
-232,684
| -8% | -$18.7M |
|
147
Monster Beverage
MNST
$89.9B
| $201M | 0.21% |
17,398,388
+10,741,284
| +161% | +$120M |
|
148
Target
TGT
$69.4B
| $196M | 0.2% |
3,544,231
-540,758
| -13% | -$33.7M |
|
149
Bristol-Myers Squibb
BMY
$130B
| $195M | 0.2% |
3,592,702
-1,123,400
| -24% | -$61.6M |
|
150
Edwards Lifesciences
EW
$53.8B
| $193M | 0.2% |
6,140,625
+413,802
| +7% | +$13M |
|
Similar funds
American Century Companies's Q1 2017 Portfolio in Review
As of Q1 2017, American Century Companies held 1,454 positions worth $96.3B, up 3.8% from $92.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
American Century Companies withdrew a net $4.83B in Q1 2017, closing 148 positions and reducing 553 holdings. Its most notable exit was Linear Technology Corp, an estimated $173M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Technology.
Against the trend, American Century Companies opened a new position in Realty Income worth $56.8M.
- American Century Companies's largest Q1 2017 buy was Realty Income: 984,062 shares worth $56.8M.
- American Century Companies added most to Procter & Gamble in Q1 2017, an estimated $255M increase.
- American Century Companies's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $2.53B.
- American Century Companies fully exited Linear Technology Corp in Q1 2017, selling an estimated $173M.
- American Century Companies's ten largest holdings make up 14% of its $96.3B portfolio in Q1 2017.
- American Century Companies opened 141 new positions and closed 148 in Q1 2017.
- American Century Companies's portfolio value rose 3.8% quarter-over-quarter to $96.3B.
Based on American Century Companies's 13F filing for Q1 2017, filed 2 May 2017.